BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30439482)

  • 21. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methyltransferase 1-mediated CpG methylation of the miR-150-5p promoter contributes to fibroblast growth factor receptor 1-driven leukemogenesis.
    Hu T; Chong Y; Cai B; Liu Y; Lu S; Cowell JK
    J Biol Chem; 2019 Nov; 294(48):18122-18130. PubMed ID: 31628193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia.
    Almotiri A; Alzahrani H; Menendez-Gonzalez JB; Abdelfattah A; Alotaibi B; Saleh L; Greene A; Georgiou M; Gibbs A; Alsayari A; Taha S; Thomas LA; Shah D; Edkins S; Giles P; Stemmler MP; Brabletz S; Brabletz T; Boyd AS; Siebzehnrubl FA; Rodrigues NP
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
    Marchand T; Pinho S
    Front Immunol; 2021; 12():775128. PubMed ID: 34721441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
    Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
    Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia.
    Chu Y; Chen Y; Li M; Shi D; Wang B; Lian Y; Cheng X; Wang X; Xu M; Cheng T; Shi J; Yuan W
    Cancer Sci; 2019 Jul; 110(7):2200-2210. PubMed ID: 31050834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase.
    Hu T; Chong Y; Qin H; Kitamura E; Chang CS; Silva J; Ren M; Cowell JK
    Oncogene; 2018 Apr; 37(14):1926-1938. PubMed ID: 29367757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.
    Daga S; Rosenberger A; Quehenberger F; Krisper N; Prietl B; Reinisch A; Zebisch A; Sill H; Wölfler A
    Cancer Med; 2019 Apr; 8(4):1771-1778. PubMed ID: 30848055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome.
    Hu T; Wu Q; Chong Y; Qin H; Poole CJ; van Riggelen J; Ren M; Cowell JK
    Leukemia; 2018 Nov; 32(11):2363-2373. PubMed ID: 29720732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.
    Patnaik MM; Gangat N; Knudson RA; Keefe JG; Hanson CA; Pardanani A; Ketterling RP; Tefferi A
    Am J Hematol; 2010 Apr; 85(4):238-42. PubMed ID: 20143402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.
    Sadras T; Perugini M; Kok CH; Iarossi DG; Heatley SL; Brumatti G; Samuel MS; To LB; Lewis ID; Lopez AF; Ekert PG; Ramshaw HS; D'Andrea RJ
    J Leukoc Biol; 2014 Jul; 96(1):83-91. PubMed ID: 24598054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature.
    Corrigan DJ; Luchsinger LL; Justino de Almeida M; Williams LJ; Strikoudis A; Snoeck HW
    J Clin Invest; 2018 Aug; 128(8):3250-3264. PubMed ID: 29878897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.
    Quek L; Otto GW; Garnett C; Lhermitte L; Karamitros D; Stoilova B; Lau IJ; Doondeea J; Usukhbayar B; Kennedy A; Metzner M; Goardon N; Ivey A; Allen C; Gale R; Davies B; Sternberg A; Killick S; Hunter H; Cahalin P; Price A; Carr A; Griffiths M; Virgo P; Mackinnon S; Grimwade D; Freeman S; Russell N; Craddock C; Mead A; Peniket A; Porcher C; Vyas P
    J Exp Med; 2016 Jul; 213(8):1513-35. PubMed ID: 27377587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The driver of malignancy in KG-1a leukemic cells, FGFR1OP2-FGFR1, encodes an HSP90 addicted oncoprotein.
    Jin Y; Zhen Y; Haugsten EM; Wiedlocha A
    Cell Signal; 2011 Nov; 23(11):1758-66. PubMed ID: 21745565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
    Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
    Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities.
    O'Reilly E; Zeinabad HA; Szegezdi E
    Blood Rev; 2021 Nov; 50():100850. PubMed ID: 34049731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
    BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia.
    Shingai Y; Yokota T; Okuzaki D; Sudo T; Ishibashi T; Doi Y; Ueda T; Ozawa T; Nakai R; Tanimura A; Ichii M; Shibayama H; Kanakura Y; Hosen N
    Stem Cells; 2021 Jun; 39(6):723-736. PubMed ID: 33539590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.